Neurology Today Editor’s Picks: Recent Episodes
Neurology Today
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the latest issue.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a pilot American Board of Psychiatry and Neurology Academic Pathway, a study of the EpiWatch app, and a new approach to magnetic resonance scanning.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a blood test that could predict cognitive decline before pathological signs, the use of tirofiban after tenecteplase for stroke, and the role of artificial intelligence in peer review.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about asundexian reducing recurrent ischemic stroke, the link between the high-dose flu vaccine and Alzheimer's dementia incidence, and the evolving role of osteopathic medicine in neurology.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about appointment wait times for commercially insured patients, post-traumatic headache severity in children with a family history of migraine, and the FDA approval of a drug for Alzheimer's agitation.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a link between higher meat and slower cognitive decline in APOE34/44 carriers, the geographic distribution of research funding, and how artificial intelligence is reshaping neurology.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a new selective dopamine agonist for people with Parkinson's disease, the use of artificial intelligence in preparing journal manuscripts, and caffeinated coffee's role in reducing dementia risk.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the increase in neurology residency matches this year, the risk of dementia in people with Type 1 diabetes, and the role of neurologists in the public health conversation.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the academic job market for fellowship graduates, the challenges of today's complex neuromuscular therapies, and the changes made in a new stroke guideline.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about acetaminophen use during pregnancy, the link between air pollution and motor neuron disease risk, and the use of fremanezumab for pediatric migraine.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about ACGME neurocritical care accreditation, how neurologists in Jamaica are recovering from hurricane damage, and the use of rituximab maintenance dosing in multiple sclerosis.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about West Nile neuroinvasive disease, what's next after NINDS director Dr. Walter Koroshetz's departure, and changes to funding for advanced practice providers' education.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about EMG expertise, GLP-1s and epilepsy risk reduction, and combination therapy for recurrent IDH-mutant astrocytoma.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the discontinuation of lasmiditan, the new DAAN designation, and the use of alteplase after eye stroke.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the growing role of genetic counselors in neurology, a wrist-worn stimulation device for essential tremor, and results from the CREST-2 study of asymptomatic carotid disease.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the benefit of shunts in idiopathic normal-pressure hydrocephalus, how neurologists drive downstream revenue, and anticoagulant monotherapy after stroke.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a p-tau217 blood test for Alzheimer's disease, the benefits of tirofiban with thrombolysis, and an AI tool that excels in diagnostic coding.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about medical school acceptance rates after the ending of affirmative action, minimally invasive surgery for hemorrhagic stroke, and the increased risk of brain tumors after traumatic brain injury.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about artificial sweeteners' impact on cognitive health, how drug company payments influence prescribing decisions, and the use of graphene technology to accelerate maturation of neurons.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about how monoclonal antibodies revolutionized neurologic treatment, why pregabalin link to increased heart failure, and a combined therapy that slows progression in primary progressive aphasia.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a PET radiotracer that shows intranasally delivered insulin enters the brain, GLP-1s and dementia risk in people with Type 2 diabetes, and how exposure to green space may reduce the risk of neurodevelopmental delays in children.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about pegivirus’s potential role in Parkinson’s disease pathology, the impact of GLP-1 receptor agonistst on idiopathic intracranial hypertension, and the geographic spread of epilepsy specialists.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the relationship between income, “food deserts,” and stroke risk; why staying active may reduce cognitive decline in patients with Parkinson's disease; and how initiating rimegepant for migraine could help reduce opioid and butalbital use.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a promising blood test to distinguish Parkinson’s disease from dementia with Lewy bodies, how CAR T-cell therapies are showing potential for patients with glioblastoma, and a new wireless electroencephalogram device that can even monitor young children with epilepsy.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about whether small fiber neuropathy is an autoimmune disorder; Merit Cudkowicz, MD, MSc, FAAN, recipient of this year’s AAN Lifetime Achievement Award for Clinically Relevant Research; and how neurologist couples pursue work-life balance.
In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about eptinezumab, a treatment for episodic cluster headache; how positioning the head flat before a thrombectomy benefited patients with large vessel occlusion stroke; and what rural neurology looks like in 2025, the first story in our new series, Neurology in America.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about upadacitinib, a new treatment for giant-cell arteritis; growing evidence linking oral health to a higher risk of neurologic conditions; and why a trial of a new meningitis B vaccine drew a mixed response.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles on the association of shortened telomeres on risk for stroke, late-life depression and dementia; affect of research funding cuts on tenure/promotion opportunities; and herpes zoster vaccine and reduced dementia risk.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles studies showing persistent fatigue after TIA, the neurologic complications of measles, and the impact of the dismantling of a CDC surveillance program of epilepsy.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about early studies finding dopamine cellular therapies were safe and tolerable for patients with Parkinson’s, use of GLP-1 agonists were associated with reduced dementia risks, and the FDA use of accelerated approvals for several neurology drugs are under scrutiny.
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles finding microplastics in the brain postmortem linked to dementia, the salary gap between men and women neurologies, and neurologists studying the impact of microgravity on the brain.
In this episodeof Neurology Today in 5, Neurology Today editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a large trial that found high-dose Vitamin D reduced MRI evidence of disease activity in patients with clinically isolated syndrome or early relapsing MS; an animal brain map, revealing changes in inflammation, immune activity, and cell repair that preceded the appearance of MS lesions; and a discussion of the challenges and opportunities of using AI in neurology education.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the newly approved drug for neurofibromatosis 1 with plexiform neuromas in adults, how neurology practices are integrating with multiple subspecialties, and the impact of federal cuts to DEI grants and research.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the impact of NIH cuts to indirect research costs, response to a new guideline on migraine prevention from ACP, and an updated position statement from the AAN on seizures, driver licensures, and medical reporting.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the larger lifetime burden of dementia than projected, an AI-fueled program that detects hidden features in EEGs for epilepsy detection, and neurology-trained pharmacists who are working with neurology departments.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on new data on IVF safety for women with MS, an elevated protein associated with loneliness, social isolation and brain function, and the role of community-based neurologists in drug development.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the pros and cons of virtual neurology education, the FDA approval of tirzepatide for obesity-related obstructive sleep apnea, and the promise of AI for glioma assessment.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the safety of middle meningeal artery embolization for chronic subdural hematoma, the processed red meat and risk for dementia, and editors’ picks for the best advances of 2024.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the higher risk for cardiovascular effects with certain antiseizure therapies on adults with epilepsy, the impact of social determinants of health on children with MS, and the status of coverage for blood-based tests for Alzheimer’s disease.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on fever prevention and stroke outcomes, the impact of air pollution and other environmental toxins on Parkinson’s, and the role of cholesterol overload in ALS progression and disease risk.
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the potential of a new blood biomarker for ALS, a PACP-targeted migraine therapy, and a real-world review of data on eculizumab for neuromyelitis optica spectrum disorder.
This Podcast is being Sponsored by LocumTenens.com
In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on Eastern equine encephalitis relief, systems developed to meet demand for anti-amyloid therapies, and a new protocol for timely diagnosis and treatment for eye stroke in the emergency department.
This Podcast is being Sponsored by LocumTenens.com
In this week’s podcast, Neurology Today’s editor-in-chief highlights new findings on brain pathways in placebo pain relief, that Parkinson’s gene variants are more common than thought, and why there is momentum behind new blood biomarker tests for Alzheimer’s.
In this week’s podcast, Neurology Today’s editor-in-chief highlights a new workgroup’s recommendations on biomarkers for diagnosing Alzheimer’s, AI’s ability to track Parkinson’s severity from brief videos, and the latest research on how racism leads to neural changes and accelerated aging.
In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the association between weight loss drugs and a rare type of optic neuropathy, ethical issues around normothermic regional perfusion, and how neurologists are onboarding and training advanced practice practitioners in comorbid cancer and stroke.
In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the complex interaction between body composition, vascular health, and neurodegenerative disease, Tenecteplase in an extended treatment window and stroke-related disability, and gene expression in cormorbid cancer and stroke.
In this week’s podcast, Neurology Today’s editor-in-chief discusses data on an angiotensin receptor for blocker for hypertension associated with reduced risk for epilepsy, a study finding first responders to 9-11 clean-up sites had an increased risk for early dementia, and dementia experts comment on approval of donanemab.
In this week’s podcast, Neurology Today’s editor-in-chief discusses data on the effectiveness of rescue therapies when endovascular thrombectomy fails, how first-seizure clinics reduce hospitalizations, and AI’s use in sleep neurology.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a paper advising against prematurely withdrawing life support for severe TBI, data showing those with the highest composite score of inflammatory markers had a greater risk for stroke, original reporting stressing that residency programs and applicants need to adopt more strategic approaches to managing the overwhelming volume of applications.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a push among neurocritical care experts to develop a code procedure for intracerebral hemorrhage, new findings showing people with Havana syndrome have functional neurologic disorder, and a study reporting distal symmetric polyneuropathy is more prevalent but less diagnosed in primary care clinics in low-income areas.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors’ response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer’s disease.
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the impact of SARS-CoV2 on dopamine neurons, a European Medicines Agency warning about valproate risks for men, and neurologists on the pros and cons of working locum tenens.
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new stories reporting on the use of AI in EMS systems for stroke detection, the association between human growth hormone and iatrogenic Alzheimer’s, and seizure dogs for refractory epilepsy.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the cerebral amyloid angiopathy as a risk factor for nontraumatic subdural hemorrhage, AI beats humans in neurology-like boards, and the impact of popular weight loss drugs on neurologic conditions.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing the rising incidence of Creutzfeldt-Jakob disease, an effective therapy for prodromal migaine, and neuroinflammation in military personnel exposed to blast injury.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on the impact of deep brain stimulation on cognition in severe traumatic brain injury and how adaptive functioning is impacted in children exposed to antiseizure drugs in utero, and the editorial board’s picks for the best advances of 2023.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing double the suicide risk among Parkinson’s patients; underrepresentation of non-White people in Alzheimer’s trial related to biomarker eligibility; early immune systems changes may play early role in ALS and Parkinson's.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing serotonin depletion associated with long COVID; implantable cardiac monitors detect Afib 3 years post-stroke; and what Medicare’s decision to cover PET amyloid scans means for neurologists.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on the risk of spontaneous intracerebral hemorrhages after blood transfusions; the burden of long distance travel to see neurologists; and two promising biomarkers for early diagnosis of Parkinson’s disease.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on blood pressure targets for stroke after endovascular therapy, changing policies on CME, and a direct-to-consumer blood test for Alzheimer’s disease.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on football and the risk for Parkinson’s disease, the potential of deep brain stimulation for recovery from stroke, and neuroprostheses for patients with anarthria.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses the Medicare’s proposed coverage of carotid stenting in asymptomatic patients,neuro-oncologists’ perspectives on a federal initiative to target persistent poverty in vulnerable patients, and the technological promise of a new optical EMG for neuromuscular disorders.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses research that assesses the safety of endovascular treatment post-stroke for people with intracranial tumors, the AANEM guideline on IVIG use for neuromuscular disorders, and the latest data on donanemab.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that associate poor oral health and risk for cognitive decline and how to manage first-ever sleep seizures that recur as well as the growth of concierge neurology.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the association between gout and neurodegenerative diseases, tenecrteplase vs.warfarin for acute stroke, expedited cognitive decline after a heart attack.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the FDA approval of an antipsychotic for agitation in dementia, elevated risk for Parkinson’s in Camp Lejeune Marines exposed to contaminated water, a gene variant delays the onset of symptoms in man with autosomal dominant Alzheimer’s.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a study on the safety of omnabotuliumtoxinA on pregnant women with migraine, the impact of the Adderall shortage on patients with ADHD and narcolepsy, and the state of AI for epilepsy. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study reporting a gene assay detected Parkinson’s before symptoms onset, life stressors greatly impact women with epilepsy during pregnancy; the role of inflammation in new-onset refractory status epilepticus.
This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study finding anticoagulants are safe for patients with atrial fibrillation and dementia, women on hormone replacement therapy had higher tau levels, and neurology residents are participants in humanities programs to foster wellness.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study finding fertility treatments did not lead to MS relapses for women, a AHA consensus statement that finds stroke systems need improvement, and ravalizumab at less frequent doses was effective for neuromyelitis optica spectrum disorder.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson’s disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the increased use of antipsychotics during the pandemic and an associated greater risk for dementia, determining the best biomarkers when considering lecanemab for Alzheimer’s, and a novel approach for managing uncomfortable neuropathic symptoms.
In this week’s podcast, Neurology Today’s editor-in-chief discusses long-term adverse outcomes from pregnancy-associated stroke, a robotic device to assist shoulder movement in ALS, and the promise of neurostimulation for refractory seizures in the ICU.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the associated risk between acute infections and dementia; alternative therapies to CPAP for sleep apnea; and Dr. Ralph Sacco’s impact on the field.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the report on outcomes of IV thrombolysis for large vessel occlusions; the discovery of a new brain layer in the subarachnoid space; and the impact of mindfulness and exercise on cognition.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the report on misdiagnosis of autoimmune encephalitis, inflationary times for neurologists in private practice, and the editorial board picks for best advances in 2022.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a comparison of spinal cord stimulation with medical management for chronic pain, earlier brain aging in Black people, and the pros/cons of working for teleneurology companies.
In this week’s podcast, Neurology Today’s editor-in-chief discusses why MS specialists advocate for rituximab for MS, how food security may relate to cognition, and a novel in utero therapy for Pompe diseasea.
In this week’s podcast, Neurology Today’s editor-in-chief discusses modifiable risk factors for monogenic stroke, what health care systems need to do to prepare for new Alzheimer’s therapies, and criteria program directors apply in selecting neurology residents.
In this week’s podcast, Neurology Today’s editor-in-chief discusses data suggesting revascular therapies are safe for patients with stroke and COVID, dementia is associated with increased suicide risk, and the potential of hyperbaric oxygen therapy for children with concussion.
In this week’s podcast, Neurology Today’s editor-in-chief discusses data suggesting allergic disease is associated with an increased risk of dementia, an increased risk of cancer in children born to women with epilepsy who took high-dose folic acid in pregnancy, and the impact of climate change on people with neurologic disorders.
In this week’s podcast, Neurology Today’s editor-in-chief discusses data suggesting vamorolone as an alternative to corticosteroids for Duchenne muscular dystrophy, how an aquaporin protein promotes amyloid clearance, and neurologic events associated with monkeypox virus.
In this week’s podcast, Neurology Today’s editor-in-chief discusses new findings on chronic kidney disease and risk for intracerebral hemorrhage, the potential of gonadotropic replacement for improving cognition in Down syndrome, and distinguishing polio from acute flaccid myelitis and other viruses.
In this week’s podcast, Neurology Today’s editor-in-chief discusses new findings on decompression for Chiari malformation, the association of atrial cardiopathy with dementia, and a neurology resident’s 3D printing of brain model.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the increased associated risk between processed foods and dementia risk, antihistamines vs. benzodiazepines for vertigo, and impostor syndrome in neurology.
In this week’s podcast, Neurology Today’s editor-in-chief discusses spinal cord stimulation for painful diabetic neuropathy, the Roe v. Wade reversal and neurology, and initiatives to diversify the neurology pipeline.
In this week’s podcast, Neurology Today’s editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.
In this week’s podcast, Neurology Today’s editor-in-chief discusses new thinking about functional neurologic disorders, the benefits of screening newborns for spinal muscular atrophy, and career advice on when to leave a job in neurology.
In this week’s podcast, Neurology Today’s editor-in-chief discusses RAAS inhibitors for brain aneurysm rupture, the impact of COVID-19 on babies exposed in utero, and how socioeconomic status, independent of genetics, affects brain development.
In this week’s podcast, Neurology Today’s editor-in-chief discusses what’s known about monkeypox, soticelstat as a potential new epilepsy therapy, and the potential of gabapentin for stroke recovery.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year’s residency match.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the challenges and opportunities of teleneurology in rural areas, the effect of childhood trauma on neurologic disorders, and genetics advances in neurology.
In this week’s podcast, Neurology Today’s editor-in-chief discusses portable low field MRI for stroke, SSRI exposure in pregnancy and risk for seizures in neonates, and disrupted neurology training in Ukraine.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the link between blood pressure trajectories in young adults and cerebral lesions in midlife, early risk factors for Parkinson’s, a newly matched neurology resident, and the winner of the Potamkin Award.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the pros/cons of gabapentin as a controlled substance, recurrent stroke risk in adults with embolic stroke of unknown source, how to become a clinician educator.
In this week’s podcast, Neurology Today’s editor-in-chief discusses the link between statins and parkinsonism, how neurologists in Ukraine are faring, why and how to discuss the costs of care with patients.
In this week’s podcast, Neurology Today’s editor-in-chief discusses how Parkinson’s experts choose among the many new and older therapies; decline of antiseizure drug levels in pregnancy, and benefits of endovascular therapy for large core stroke.
In this week’s podcast, Neurology Today’s editor-in-chief discusses a call to action to address unmet needs of women with Parkinson’s; a promising advance for people with severe spinal cord injuries, and a novel gene therapy for limb girdle muscular dystrophy.
In this week’s podcast, Neurology Today’s editor-in-chief discusses gender bias in Medicare criteria for sleep apnea; delayed cerebral ischemia with cannabis use; and income disparities between male and female neurologists, and more!
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the February 3, 2022 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 20, 2022 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 6, 2022 issue
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 16, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 2, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 18, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 4, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 21, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 7, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 16, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 2, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the August 19, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the August 5, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the July 22, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the July 8, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 17, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 3, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the May 20, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the May 6, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the April 15, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the April 1, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the March 4, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the February 18, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the February 4, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 21, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 7, 2021 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 17, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 3, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 5, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 5, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 22, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 8, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 17, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 3, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the August 20, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the August 6, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the July 23, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the July 9, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 18, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 4, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the May 21, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the May 5, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the April 16, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the March 19, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the March 5, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the February 20, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the February 6, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 23, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 9, 2020 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 19, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 5, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 21, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 7, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 17, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 3, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 19, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 5, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the August 22, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the August 8, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the July 25, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the July 11, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 20, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 6, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the May 23, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the May 9, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the April 18, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the April 4, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the March 21, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the March 7, 2019 issue.
Joseph E. Safdieh, MD, FAAN, editor-in-chief of Neurology Today interviews Neurology Today editorial board member James Grotta, MD, FAAN, director of stroke research at Memorial Hermann-Texas Medical Center in Houston, about his top picks for the Best Advances of 2018—new developments in stroke research and treatment.
Joseph E. Safdieh, MD, FAAN, editor-in-chief of Neurology Today interviews Neurology Today editorial board member Jennifer Bickel, MD, FAAN, about her pick for the Best Advances of 2018—the all-women slate of AAN officers and the move toward gender equity in neurology.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the February 21, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the February 7, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 24, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the January 10, 2019 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 20, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the December 6, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 15, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the November 1, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 18, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the October 4, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 20, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the September 6, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the August 16, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the August 2, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the July 19, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the July 5, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 21, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the June 7, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the May 17, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the May 3, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the April 19, 2018 issue.
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the April 5, 2018 issue.